Achieve Life Sciences, Inc. (ACHV) vs DBV Technologies S.A. (DBVT)

Achieve Life Sciences, Inc. and DBV Technologies S.A. are both Biotechnology companies. Achieve Life Sciences, Inc. and DBV Technologies S.A. are of similar size ($723.3M and $658.6M). Achieve Life Sciences, Inc. grew revenue faster over the last twelve months: −5.58% against −33.4%. Achieve Life Sciences, Inc. has the higher net margin (0.00% vs −5,547.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Achieve Life Sciences, Inc. leads on 11 and DBV Technologies S.A. on 5.

Valuation

Metric ACHV DBVT Biotechnology median
P/E n/m n/m 10.96
P/S 40.07 279.11 9.52
P/B n/m 7.02 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales 29.26 234.82 9.00
Earnings yield (22.86%) (26.72%) (32.09%)
Free cash flow yield (7.42%) (18.39%) (22.62%)

Profitability

Metric ACHV DBVT Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (5,571.63%) 0.00%
Net margin 0.00% (5,547.30%) 0.00%
Free cash flow margin 0.00% (5,131.50%) 0.00%
Return on equity (844.99%) (205.75%) (50.12%)
Return on assets (91.46%) (127.19%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACHV DBVT Biotechnology median
Revenue growth (TTM) (5.58%) (33.42%) 6.78%
EPS growth (last fiscal year) (0.81%) 10.26% 29.88%
Revenue growth, 5-year CAGR (17.95%) (12.95%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACHV DBVT Biotechnology median
Debt to equity (1.11) 0.00 0.00
Current ratio 0.95 3.24 4.74
Net debt to EBITDA 0.36 1.35 1.01

Dividend

Metric ACHV DBVT Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric ACHV DBVT Biotechnology median
Market cap 658.58m 723.29m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack